Relation of a hypoxia metagene derived from head and neck cancer to prognosis of multiple cancers.
Affymetrix U133plus2 GeneChips were used to profile 59 head and neck squamous cell cancers. A hypoxia metagene was obtained by analysis of genes whose in vivo expression clustered with the expression of 10 well-known hypoxia-regulated genes (e.g., CA9, GLUT1, and VEGF). To minimize random aggregatio...
Main Authors: | Winter, S, Buffa, F, Silva, P, Miller, C, Valentine, H, Turley, H, Shah, K, Cox, G, Corbridge, R, Homer, J, Musgrove, B, Slevin, N, Sloan, P, Price, P, West, C, Harris, A |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2007
|
Similar Items
-
Large meta-analysis of multiple cancers reveals a common, compact and highly prognostic hypoxia metagene.
by: Buffa, F, et al.
Published: (2010) -
hsa-mir-210 is a marker of tumor hypoxia and a prognostic factor in head and neck cancer.
by: Gee, H, et al.
Published: (2010) -
An in vivo hypoxia metagene identifies the novel hypoxia inducible factor target gene SLCO1B3
by: Ramachandran, A, et al.
Published: (2013) -
An in vivo hypoxia metagene identifies the novel hypoxia inducible factor target gene SLCO1B3.
by: Ramachandran, A, et al.
Published: (2013) -
Large meta-analysis of multiple cancers reveals a common, compact and highly prognostic hypoxia metagene (British Journal of Cancer (2010) 102 (428435) DOI:10.1038/sj.bjc.6605450))
by: Buffa, F, et al.
Published: (2010)